Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1976
The L1210 leukemia cell bears a B lymphocyte specific, non-H-2 linked alloantigenJ G Freund, A Ahmed, R E Budd, et al.Blood|January 15, 1992
Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cellsH Avraham, E Vannier, S Cowley, et al.Blood|January 15, 1994
Suppression of juvenile chronic myelogenous leukemia colony growth by interleukin-1 receptor antagonistR Schirò, D Longoni, V Rossi, et al.Infection and Immunity|December 22, 2005
MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in miceK A Rogers, A B Rogers, B A Leav, et al.Journal of Clinical Immunology|May 1, 1997
Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndromeJ G Cannon, J B Angel, L W Abad, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1979
Characterization of the immunosuppressive state during Schistosoma mansoni infectionA M Attallah, A H Smith, K D Murrell, et al.Blood|August 1, 1997
The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infectionsM van Deuren, J van der Ven-Jongekrijg, E Vannier, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1993
Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humansE V Granowitz, R Porat, J W Mier, et al.Blood|November 15, 1993
Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humansE V Granowitz, R Porat, J W Mier, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1995
A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responsesA E Chernoff, E V Granowitz, L Shapiro, et al.Pageof 7